Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25622,902,2.16 [1.74-2.68],2.2521400991120618e-12
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25647,142,4.19 [2.57-6.83],9.133141242179662e-09
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27234,153,1.55 [0.92-2.60],0.0993947920075332
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20367,500,3.06 [2.31-4.06],5.414237221948871e-15
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27172,91,1.38 [0.71-2.69],0.3456976630613618
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26452,78,4.33 [2.25-8.33],1.1233367945694904e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28214,90,1.40 [0.71-2.73],0.3287014934702659
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28233,62,1.65 [0.75-3.63],0.21527031400397
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25891,45,1.49 [0.57-3.86],0.4122534781313305
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27694,107,3.20 [1.81-5.63],5.7937878280221816e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27654,67,3.83 [1.92-7.67],0.0001452708915403
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28275,66,1.60 [0.73-3.50],0.2408192209324301
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28237,99,1.67 [0.88-3.16],0.1180108632898596
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28228,90,1.40 [0.71-2.77],0.3327307607088989
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,28038,43,2.33 [0.92-5.89],0.0743635605519785
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27403,395,2.01 [1.47-2.75],1.316817385306227e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27155,147,2.52 [1.53-4.16],0.0002893426664306
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27261,253,1.96 [1.33-2.89],0.0007084606379139
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24533,30,0.89 [0.27-2.99],0.8552878310423617
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24552,49,0.86 [0.33-2.27],0.7640044081819312
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24631,128,1.39 [0.78-2.48],0.2661239799521565
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24636,133,1.54 [0.88-2.70],0.1336256941196814
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13793,295,1.24 [0.84-1.85],0.2821351928274218
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11032,27,0.67 [0.21-2.18],0.5099440118766083
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24550,47,2.03 [0.82-5.03],0.1279966347887496
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26117,823,2.58 [2.06-3.22],1.0495016817906884e-16
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27201,201,1.32 [0.84-2.07],0.2236668088170942
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27853,80,1.39 [0.69-2.81],0.3631525747431081
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28349,73,1.41 [0.68-2.95],0.3600047678431008
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,28107,47,2.69 [1.16-6.22],0.0210638273892582
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28356,40,1.41 [0.51-3.85],0.506562142292748
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Stomach,28397,33,1.06 [0.34-3.26],0.9253447819101964
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,28088,298,1.23 [0.84-1.79],0.286972989255147
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28328,116,1.23 [0.67-2.24],0.501520588444179
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28332,96,1.36 [0.71-2.62],0.359672288878366
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28295,44,0.66 [0.25-1.74],0.4014844077497331
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",28296,44,0.66 [0.25-1.74],0.4010287029233483
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,28188,251,0.73 [0.48-1.11],0.13781028973964
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28357,112,0.72 [0.39-1.33],0.2919448945368127
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,28265,189,1.25 [0.78-2.00],0.3520327437681305
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of breast,15669,94,1.38 [0.69-2.76],0.3666352711521341
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Leiomyoma of uterus,15302,690,0.79 [0.61-1.02],0.0724877528501831
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27357,199,2.52 [1.63-3.90],3.5239859387869975e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27245,356,1.99 [1.42-2.80],6.525586626683517e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27245,356,1.99 [1.42-2.80],6.525586626683517e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26017,362,2.21 [1.59-3.08],2.588212528367101e-06
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27918,80,1.55 [0.75-3.19],0.2367404106540609
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28129,106,1.82 [0.99-3.34],0.0527704692374841
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24904,702,2.14 [1.68-2.72],5.522881906310817e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27070,441,1.81 [1.33-2.45],0.0001417147336705
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26565,117,3.22 [1.84-5.64],4.347432470241654e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27630,54,3.79 [1.84-7.81],0.0003097869157217
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26550,102,3.66 [2.03-6.61],1.6667166865114352e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26778,330,3.35 [2.40-4.68],1.1200282622715077e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26770,322,3.35 [2.39-4.69],2.0550782899040058e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26433,186,1.11 [0.67-1.84],0.6744925873393016
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26437,183,1.17 [0.70-1.94],0.5433713462532885
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24737,535,1.88 [1.43-2.48],6.84237035825155e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24277,75,1.91 [0.94-3.87],0.0742393360674078
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24691,489,1.90 [1.43-2.54],1.221782886621214e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24245,43,1.21 [0.45-3.26],0.7032195389870086
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24280,78,3.17 [1.64-6.12],0.0005902648070372
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,24644,777,3.62 [2.88-4.55],1.595740795317074e-28
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24166,299,5.52 [3.90-7.80],4.331574802773145e-22
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27958,230,4.77 [3.29-6.92],1.913195871749496e-16
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28027,165,5.37 [3.49-8.26],2.179771096729849e-14
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26389,84,5.62 [3.14-10.06],6.000970484505983e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28281,84,4.62 [2.59-8.26],2.3062439560926605e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23951,84,5.99 [3.33-10.76],2.1904999837284957e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,26405,100,7.14 [4.16-12.26],9.761704363677904e-13
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,26365,68,4.11 [2.16-7.83],1.7195593307369428e-05
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23940,73,2.04 [0.98-4.22],0.056084555674517
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24264,397,3.36 [2.46-4.58],1.831474574484604e-14
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,26646,344,2.87 [2.08-3.96],1.3237746288112427e-10
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,24110,303,3.37 [2.38-4.79],1.0640226824677943e-11
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24013,146,2.89 [1.74-4.81],4.164930332592553e-05
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Other anxiety disorders,26869,70,2.95 [1.49-5.86],0.0019206944330507
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,25263,1466,1.55 [1.30-1.84],7.292225637515511e-07
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23562,164,2.36 [1.45-3.82],0.0005012691352154
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28192,133,2.66 [1.57-4.50],0.0002567845038699
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27031,496,1.62 [1.22-2.16],0.0008462235293198
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,26705,170,3.67 [2.37-5.70],6.6600857654607375e-09
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,26637,102,1.42 [0.75-2.70],0.2800623436524747
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28023,92,1.45 [0.74-2.84],0.2784067956549984
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27899,39,1.04 [0.37-2.89],0.9417904369046992
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,26710,175,0.81 [0.50-1.30],0.3752992811168913
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,27772,137,0.90 [0.53-1.54],0.6975101428107594
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27260,625,1.09 [0.84-1.41],0.5317310051498984
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26777,142,1.96 [1.16-3.33],0.0122209769803673
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26968,333,1.00 [0.70-1.42],0.9807895151866308
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28174,86,2.81 [1.48-5.31],0.0015417052911642
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,28142,54,2.62 [1.17-5.87],0.0187285191436576
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,27961,126,1.52 [0.86-2.68],0.1470758676257185
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27916,313,1.26 [0.87-1.81],0.224376710573472
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27772,169,1.10 [0.67-1.81],0.7106746812644509
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27693,90,1.50 [0.76-2.98],0.2405970330653629
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27707,104,1.14 [0.60-2.16],0.6855301233181333
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27654,51,2.24 [0.94-5.35],0.0694275817921765
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26660,65,3.14 [1.52-6.47],0.0019226807010164
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26777,182,1.73 [1.09-2.76],0.0205076739716509
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27776,132,1.82 [1.05-3.14],0.0326253623992595
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28144,24,4.08 [1.28-12.99],0.0174522822375889
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1777,24,1.38 [0.40-4.71],0.6083293996240804
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26391,24,4.61 [1.47-14.44],0.0087986605362488
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28015,50,1.83 [0.76-4.39],0.1776117823235283
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27992,27,2.47 [0.78-7.84],0.1239147761804434
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27918,92,1.62 [0.82-3.18],0.1618581504788642
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27972,99,1.39 [0.73-2.65],0.3163868276357615
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28267,126,1.67 [0.96-2.91],0.0692694137322153
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27867,90,1.17 [0.59-2.31],0.6456450757283239
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22230,1982,2.21 [1.89-2.60],2.0300910539421121e-22
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28067,39,3.62 [1.43-9.19],0.0068074967332638
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23304,1322,2.29 [1.89-2.76],8.290209668686238e-18
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,23327,1345,2.24 [1.86-2.71],2.7314111907887537e-17
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22030,48,1.51 [0.60-3.79],0.3794260602723593
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26862,570,1.82 [1.40-2.36],8.447275115826813e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,26646,354,1.68 [1.21-2.35],0.0022063996632523
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27674,140,1.63 [0.97-2.74],0.0649633898799196
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27799,265,1.77 [1.21-2.58],0.0031183308062577
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28290,60,3.04 [1.47-6.28],0.0026162514574071
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26456,164,1.84 [1.14-2.97],0.0119354150282991
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26702,421,1.64 [1.21-2.23],0.0014429412591276
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27869,80,1.52 [0.75-3.08],0.2479364663859283
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27864,178,1.72 [1.08-2.76],0.0228563494575714
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27852,63,1.99 [0.91-4.33],0.0830110306256852
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27853,64,2.02 [0.93-4.36],0.0736867988702495
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22042,60,2.04 [0.89-4.68],0.0919674181746985
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25734,46,1.82 [0.73-4.53],0.1968487303429174
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,25763,75,1.16 [0.55-2.44],0.6973568823374305
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19416,95,2.29 [1.17-4.49],0.015914788164462
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19512,191,2.79 [1.75-4.46],1.827591721512136e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,25730,42,1.18 [0.44-3.18],0.7403227555910384
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25750,62,1.95 [0.89-4.27],0.0962094516591374
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27885,120,2.78 [1.63-4.73],0.0001659061907701
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27851,115,1.21 [0.67-2.19],0.5325692880133129
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27885,85,0.98 [0.49-1.98],0.965055375695558
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27934,74,1.15 [0.55-2.43],0.7046368037558368
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27653,51,2.26 [1.00-5.12],0.0507244006601724
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27687,85,3.51 [1.92-6.43],4.639364212515796e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27139,117,1.90 [1.07-3.40],0.0294872386385334
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27119,97,2.10 [1.12-3.94],0.0211084279731329
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28231,93,1.93 [1.02-3.67],0.0439746056051576
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,27466,444,0.86 [0.62-1.18],0.3381847097676129
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,27641,55,2.35 [1.03-5.36],0.0416008304717299
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,24032,1960,1.76 [1.51-2.05],4.163510641992253e-13
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28166,139,1.94 [1.15-3.28],0.0130822607381349
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27172,190,1.90 [1.20-3.01],0.0059070605811352
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27143,161,2.07 [1.26-3.38],0.003867515288326
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27777,214,2.34 [1.55-3.53],5.562875948893064e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27775,212,2.36 [1.56-3.57],4.628203821200304e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27496,669,1.14 [0.88-1.46],0.3226244070657365
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,26923,96,1.57 [0.82-3.02],0.1718362779218256
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,26934,107,0.57 [0.31-1.05],0.070510941688374
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27257,430,1.40 [1.02-1.91],0.0349730144488005
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,27057,230,1.26 [0.82-1.93],0.2959471622981496
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16382,50,2.93 [1.20-7.15],0.0183651031116092
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25993,884,1.54 [1.23-1.91],0.0001204518724042
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,27676,108,1.86 [1.05-3.29],0.0343734093925793
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27676,108,1.86 [1.05-3.29],0.0343734093925793
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27676,108,1.86 [1.05-3.29],0.0343734093925793
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26603,802,1.35 [1.07-1.70],0.0103643126092883
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,21739,802,1.61 [1.27-2.04],8.113045493159484e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21595,802,1.62 [1.28-2.06],5.762795839597254e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21723,786,1.62 [1.28-2.06],7.108972009640466e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28205,54,4.99 [2.44-10.19],1.0351045919294573e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,27053,40,8.33 [3.68-18.85],3.655287609315292e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28267,40,7.11 [3.28-15.43],7.046611868427226e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27047,34,,
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,27027,77,2.68 [1.34-5.36],0.0053130260332414
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,27128,178,2.36 [1.49-3.73],0.0002349659062755
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27536,85,2.33 [1.22-4.47],0.0107541162450293
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20101,5213,1.80 [1.61-2.00],2.803894907225877e-26
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27776,506,1.18 [0.88-1.58],0.2677002922842086
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28323,141,1.06 [0.60-1.86],0.8390079951912313
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,28329,132,1.18 [0.66-2.11],0.5746594608562777
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,27397,127,1.24 [0.70-2.18],0.4564174548884444
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27379,109,1.17 [0.63-2.17],0.6298574534556018
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28308,156,1.06 [0.62-1.80],0.8404726762133755
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27367,97,1.63 [0.85-3.12],0.1384105875635218
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27104,66,1.09 [0.49-2.40],0.835932841915318
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28270,46,0.68 [0.27-1.72],0.4151734391846238
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22825,205,2.03 [1.32-3.13],0.0013017087323947
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24378,1758,1.85 [1.58-2.17],3.849080562210378e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,22892,272,2.33 [1.60-3.39],1.0278897781334352e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23177,557,1.89 [1.44-2.48],5.220291358875661e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22686,66,3.27 [1.60-6.67],0.001112483942239
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22748,128,2.12 [1.22-3.68],0.0074433352750421
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22651,31,5.74 [2.24-14.72],0.000276479760046
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,22724,104,1.65 [0.89-3.07],0.1141725600153354
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,22724,104,2.51 [1.40-4.49],0.002000218568451
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28291,73,2.23 [1.11-4.45],0.0234060907934133
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,22722,102,0.94 [0.50-1.78],0.8567333300681781
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23265,645,2.05 [1.59-2.63],2.2323359532715067e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,28208,164,1.16 [0.69-1.93],0.5737435373321418
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,23008,388,1.32 [0.94-1.84],0.1092715477184544
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22736,116,2.59 [1.45-4.62],0.0013477010705829
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28197,190,2.02 [1.28-3.18],0.0024076388738624
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,28172,128,0.97 [0.54-1.73],0.913566323310428
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,25592,1188,1.48 [1.22-1.79],5.9750102624683134e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,24805,401,0.94 [0.68-1.31],0.7234065197131458
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,24525,121,1.13 [0.64-2.03],0.6690139556598695
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,24500,96,2.24 [1.20-4.18],0.0109870570696474
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25009,605,2.04 [1.58-2.64],5.584331966775844e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27501,765,2.01 [1.60-2.53],2.15417835342527e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,23381,1688,1.70 [1.45-2.00],1.8140357353751864e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28053,75,2.86 [1.43-5.71],0.0029427472164193
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28311,106,2.24 [1.23-4.08],0.0086047704397678
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,26842,106,2.32 [1.27-4.23],0.00615577494111
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26817,81,1.82 [0.90-3.67],0.0935120227376982
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28256,135,1.77 [1.02-3.05],0.041203491580291
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,26871,135,1.83 [1.06-3.18],0.0303906948991334
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26853,117,2.93 [1.67-5.16],0.0001875815689685
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27343,607,2.17 [1.68-2.80],2.3620895073313364e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27338,602,2.08 [1.61-2.70],2.1578636868058612e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21767,74,1.63 [0.77-3.44],0.1994207561578499
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal stricture,28049,74,1.47 [0.70-3.08],0.3108301058407104
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21744,51,2.01 [0.83-4.84],0.1196481536768031
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22000,307,1.88 [1.31-2.70],0.000669453598627
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21873,180,1.80 [1.12-2.90],0.0157992860694057
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21948,255,2.75 [1.87-4.04],2.4249370585399645e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,27207,229,2.61 [1.74-3.90],2.991006286258296e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27965,83,1.90 [0.96-3.78],0.0660702173122551
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21872,179,2.10 [1.30-3.37],0.0022741697330432
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21784,91,1.44 [0.74-2.82],0.2840395484827183
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22484,791,1.54 [1.22-1.94],0.0003019667019674
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,21878,185,2.05 [1.29-3.25],0.0023319290167233
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27953,71,1.36 [0.63-2.93],0.4328370960764963
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,27646,123,9.49 [5.94-15.16],4.9819348463496236e-21
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,27588,65,8.10 [4.21-15.59],3.7469603094106524e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27135,536,1.92 [1.46-2.52],3.214323280872636e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,27021,422,1.61 [1.18-2.20],0.0028268151240065
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,26679,80,2.79 [1.42-5.52],0.003066233327884
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26645,46,6.37 [2.92-13.90],3.231449230697984e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,26661,62,2.72 [1.30-5.69],0.0081170237178258
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28220,62,2.64 [1.26-5.52],0.0101088762485762
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27102,286,2.38 [1.66-3.41],2.178371293055415e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26882,66,2.54 [1.21-5.37],0.0142886111361619
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,26867,51,2.50 [1.07-5.82],0.0342085760767978
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26859,43,3.05 [1.22-7.62],0.0171903681363236
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27000,184,2.31 [1.48-3.59],0.0002094973442809
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,26995,179,2.31 [1.48-3.62],0.0002455834968807
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25746,1502,1.57 [1.32-1.86],3.351396221426241e-07
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28006,100,2.73 [1.49-4.98],0.0010982939559746
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27950,473,1.23 [0.91-1.65],0.1797255563365908
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27268,539,1.69 [1.28-2.23],0.0001945071814726
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27589,398,1.39 [1.01-1.92],0.0421238447554554
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27296,105,1.98 [1.09-3.60],0.024992394736536
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27417,226,1.55 [1.01-2.35],0.0427243452991354
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28134,85,3.13 [1.65-5.94],0.0004575829049129
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28119,70,3.92 [1.99-7.75],8.085400066337259e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28099,50,5.56 [2.59-11.93],1.0800354247270556e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28219,35,2.23 [0.77-6.44],0.1386334477338865
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28216,32,2.45 [0.81-7.38],0.1109464921779055
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27542,65,1.21 [0.55-2.68],0.6371059984261735
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27837,360,1.14 [0.81-1.61],0.44572242878552
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26797,68,0.72 [0.33-1.58],0.4154198885996172
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26828,99,1.74 [0.92-3.30],0.0896972281288239
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26812,83,1.69 [0.84-3.41],0.13889115614111
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26946,217,1.54 [0.99-2.39],0.0536120230287519
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26917,188,1.39 [0.86-2.23],0.1766403576598813
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21978,3553,1.43 [1.27-1.61],7.527807056064255e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23626,1880,1.32 [1.13-1.54],0.0005473762040586
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25925,1121,1.59 [1.31-1.94],3.060643234974749e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21864,118,3.52 [2.03-6.11],7.71590933105174e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22092,346,2.79 [2.00-3.89],1.6841821180992043e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28051,112,2.99 [1.72-5.22],0.0001088693707938
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28068,100,3.23 [1.81-5.75],7.192375766155121e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22405,659,1.23 [0.95-1.59],0.1194147603124804
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",25027,659,1.17 [0.91-1.51],0.2317418954586139
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21792,46,3.02 [1.24-7.38],0.0151513844309315
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27999,45,2.98 [1.24-7.13],0.0142256196841336
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21902,156,2.20 [1.34-3.63],0.0019634575433332
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21770,24,1.75 [0.48-6.39],0.3939186725485682
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21873,127,0.82 [0.46-1.47],0.5106503672361749
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28282,62,0.76 [0.34-1.69],0.4968960569564539
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22073,327,1.23 [0.86-1.77],0.2624298090141863
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21971,225,1.61 [1.05-2.46],0.0283476760596883
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23001,1255,1.21 [1.00-1.47],0.0474865105449651
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21783,37,1.27 [0.43-3.76],0.6635670821606234
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21923,177,1.10 [0.67-1.83],0.7001765200463088
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21782,36,0.94 [0.31-2.82],0.9088130509857224
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21776,30,0.41 [0.15-1.16],0.0923679651656025
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22274,528,0.98 [0.73-1.31],0.8684978659412436
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22185,439,0.94 [0.68-1.29],0.7091578693931474
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22473,284,2.10 [1.45-3.05],9.901595735357864e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27996,156,3.51 [2.19-5.61],1.6477870965853085e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27881,41,3.35 [1.36-8.23],0.0083304217328088
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25391,49,0.64 [0.26-1.57],0.3342468914415017
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25563,221,1.71 [1.11-2.62],0.0139998375361083
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26256,914,1.61 [1.30-2.00],1.2581851811234595e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25480,138,1.59 [0.93-2.72],0.0931117270749543
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25399,57,1.71 [0.74-3.95],0.2122688171195774
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26112,770,1.69 [1.34-2.13],1.0021508151052696e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25402,60,1.64 [0.73-3.71],0.2336645603475191
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25595,253,1.11 [0.74-1.68],0.6078359445007879
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25458,116,1.36 [0.74-2.49],0.3280105870628824
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25415,73,1.87 [0.89-3.93],0.1001397656421267
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25492,150,1.30 [0.77-2.20],0.334380943028208
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25410,68,2.99 [1.45-6.19],0.0030700359123715
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25669,327,2.59 [1.85-3.63],3.463796448126552e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25095,291,1.56 [1.07-2.28],0.0200684367463499
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24859,55,1.89 [0.82-4.38],0.1374427854071019
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24859,55,2.30 [1.00-5.26],0.0493351286643149
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24923,119,1.20 [0.66-2.18],0.5507979387814801
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24862,58,1.24 [0.53-2.92],0.6154989294416724
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24870,66,3.24 [1.57-6.71],0.0015149313101067
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24854,50,2.60 [1.10-6.13],0.029611030066113
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25034,230,1.04 [0.68-1.60],0.8536950596420758
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24857,53,1.09 [0.45-2.65],0.8468108639301173
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24857,53,1.00 [0.41-2.40],0.9938862883367762
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24914,110,1.27 [0.68-2.34],0.4548047263867832
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24877,73,2.22 [1.08-4.58],0.0305442891059188
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25240,436,1.79 [1.32-2.42],0.0001763245546476
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24952,148,1.29 [0.77-2.19],0.3356136431914818
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25028,224,2.24 [1.48-3.38],0.000125452392741
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26989,99,2.01 [1.09-3.74],0.0262243575790047
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27231,341,1.47 [1.04-2.08],0.0302542938219981
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26948,58,2.45 [1.12-5.38],0.0253441593338963
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26959,69,1.10 [0.50-2.43],0.813124501032143
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27005,115,0.97 [0.53-1.78],0.9172372173504042
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24005,4448,1.15 [1.03-1.29],0.0107050514783129
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11517,416,1.27 [0.93-1.73],0.1352749656952533
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26834,208,1.04 [0.66-1.63],0.8730441247795345
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26679,53,0.83 [0.34-2.00],0.6725773380725679
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26992,44,0.94 [0.36-2.48],0.9035649404751684
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26996,48,2.03 [0.84-4.91],0.1171340925557099
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27001,53,1.88 [0.78-4.50],0.1572737282318632
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28011,241,1.66 [1.11-2.49],0.0139064090107604
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28085,52,1.06 [0.44-2.56],0.893552329368464
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27938,168,1.71 [1.06-2.77],0.0291925791537279
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27865,95,1.28 [0.67-2.47],0.4567146254656933
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26847,891,1.36 [1.09-1.69],0.0067148444442725
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,26041,85,1.44 [0.71-2.90],0.3111475621317054
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26023,67,1.68 [0.78-3.62],0.1893997042768639
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26139,183,1.44 [0.90-2.30],0.1310328029302434
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26045,89,1.19 [0.60-2.38],0.6171554547635794
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26582,626,1.58 [1.22-2.05],0.0005418457889243
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11174,73,0.82 [0.39-1.70],0.5921738228884448
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11137,36,1.13 [0.40-3.25],0.813698194481703
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,11139,38,1.36 [0.50-3.71],0.5443018298362273
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11194,93,1.96 [1.05-3.66],0.0343397180311642
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11167,66,1.14 [0.53-2.46],0.7298303590092432
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11205,104,1.33 [0.72-2.44],0.3580112577828805
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15521,251,0.87 [0.56-1.33],0.515919536714692
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15342,72,0.66 [0.30-1.43],0.286570590410405
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15361,91,0.95 [0.46-1.95],0.8906146558585607
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15325,55,1.00 [0.40-2.52],0.99167339212202
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15481,393,0.78 [0.55-1.10],0.1519614457018043
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15170,82,0.71 [0.34-1.47],0.3514084313030116
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15282,194,0.93 [0.57-1.51],0.7603717428563881
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14272,2803,1.03 [0.90-1.19],0.6454570842383611
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Endometriosis,11767,298,0.77 [0.52-1.13],0.1835100656246515
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11562,93,1.05 [0.52-2.13],0.8852730367185498
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11582,113,0.54 [0.31-0.96],0.0353090411570988
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11779,310,1.53 [1.05-2.25],0.0285729370474854
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11777,308,1.29 [0.87-1.91],0.2015254092933468
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11954,485,0.69 [0.50-0.93],0.0167006028273553
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11638,169,0.85 [0.50-1.43],0.5374650001692247
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11691,222,0.85 [0.54-1.33],0.4664391843929552
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11553,84,0.77 [0.37-1.60],0.4895666871678283
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11610,141,1.33 [0.75-2.37],0.3335243517457013
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15673,203,1.19 [0.73-1.92],0.4843557025454768
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15683,195,1.25 [0.77-2.04],0.3694572420615482
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15702,112,0.91 [0.48-1.74],0.7780645862370161
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15693,121,0.89 [0.48-1.65],0.7002075769044274
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11543,74,1.09 [0.50-2.39],0.8279031505225586
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11531,62,0.62 [0.27-1.39],0.2430204907290128
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11545,76,0.52 [0.26-1.04],0.063712670007678
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Irregular menses,15595,383,1.09 [0.77-1.55],0.6185699308236704
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12631,1162,1.24 [1.01-1.52],0.0435323435081938
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12266,797,1.25 [0.97-1.59],0.0787918777467177
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15681,158,0.90 [0.53-1.55],0.7102699227445746
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11828,359,1.45 [1.01-2.08],0.0453785678495202
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11752,283,0.95 [0.63-1.42],0.8009779021932151
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11738,269,0.78 [0.51-1.18],0.2356545222078523
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female infertility,11585,116,0.63 [0.35-1.14],0.1238695282280071
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11578,109,0.65 [0.35-1.20],0.1665879548877643
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15697,887,0.85 [0.66-1.09],0.1925646206940291
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15702,1206,0.85 [0.68-1.07],0.1717168885842276
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15699,481,0.74 [0.54-1.02],0.0652282910150556
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15356,138,0.74 [0.41-1.35],0.3256429192848847
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15411,193,0.76 [0.47-1.23],0.2642575830859642
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15385,167,0.55 [0.34-0.91],0.0199899146567858
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15715,165,1.25 [0.72-2.15],0.4263918843138958
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15717,162,1.26 [0.73-2.18],0.4154461460035163
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15713,418,0.85 [0.60-1.21],0.366072849069233
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15420,125,0.81 [0.44-1.50],0.5067567151950185
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15525,230,1.08 [0.68-1.71],0.7516565518945382
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14960,150,0.82 [0.46-1.44],0.4824717007092638
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,15013,203,0.77 [0.48-1.24],0.2755439679340904
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,15061,251,1.20 [0.77-1.87],0.4299707541973048
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14961,151,0.65 [0.38-1.11],0.1171476917629643
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14949,139,0.53 [0.31-0.89],0.0177269959093716
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14963,153,0.48 [0.29-0.79],0.0043067426549404
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14728,232,0.64 [0.40-1.02],0.058472460816095
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14934,438,0.84 [0.59-1.20],0.3476967825296766
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15168,672,0.88 [0.65-1.19],0.40894554760327
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15720,172,0.83 [0.49-1.40],0.4802715777394912
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14252,131,0.78 [0.42-1.45],0.4249387079227433
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14599,103,0.93 [0.46-1.87],0.8337165005418061
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15726,346,0.68 [0.47-0.98],0.0393584396949439
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15643,263,0.66 [0.44-1.01],0.0532354481239289
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15713,255,1.01 [0.65-1.57],0.9671612879819826
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15704,246,1.03 [0.66-1.61],0.8990815220828741
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28143,37,0.87 [0.30-2.53],0.8021446311267658
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26711,535,1.55 [1.17-2.04],0.0023025427637539
